In all cases, GLIPR1 demonstrated tumour suppressor activity in vitro [24–29], and, furthermore, GLIPR1 expression was shown to suppress prostate cancer tumour growth in vivo [30]. This evidence concerns the gene GLIPR1 and neoplasm.